Document:

Summary of Salaries for Named Executive Officers

 Exhibit 10.12(a) 

SUMMARY OF SALARIES FOR 
 NAMED EXECUTIVE OFFICERS 
 (as of December 31, 2011) 

The following summarizes, as of December 31, 2011, the salaries of the Company’s Chief Executive Officer and the other officers
who were named in the Summary Compensation Table in the proxy statement for the Company’s 2011 Annual Meeting of Stockholders (the “Named Executive Officers”). Albert E. Heacox, Ph.D., retired from his employment with the Company
effective December 31, 2011. 
 The executive officers of the Company serve at the discretion of the Board of Directors.
The Compensation Committee of the Board reviews and determines the salaries that are paid to the Company’s executive officers, including the Named Executive Officers. 

 

					
	 Named Executive Officer
	  	Salary	 
	 Steven G. Anderson

Chairman of the Board, President, and Chief Executive Officer
	  	$	637,806	  
	 D. Ashley Lee

Executive Vice President, Chief Operating Officer, and Chief Financial Officer
	  	$	361,424	  
	 Gerald B. Seery

Senior Vice President, Sales and Marketing
	  	$	290,000	  
	 Jeffrey W. Burris

Vice President and General Counsel
	  	$	290,000	  
	 Albert E. Heacox, Ph.D.

Former Senior Vice President, Research and Development
	  	$	290,037Summary of Modifications to Compensation Arrangements with Albert E. Heacox

 Exhibit 10.12(b) 

SUMMARY OF MODIFICATIONS TO COMPENSATION ARRANGEMENTS WITH ALBERT E. HEACOX, PH.D 

On December 21, 2011, the Compensation Committee (the “Committee”) of the Board of Directors of CryoLife, Inc. (the
“Company”) approved certain modifications of the Company’s compensation arrangements with Albert E. Heacox, Ph.D., Senior Vice President, Research and Development, in connection with his retirement from the Company, which was
effective December 31, 2011. 
 The modifications to Dr. Heacox’s compensation arrangements were as follows:

  

	 	•	 	 With respect to a restricted stock award of 7,500 shares that was granted on February 16, 2009, the terms of which provided that vesting was
dependent on employment at the time of vesting, the Committee accelerated the vesting of the award from February 16, 2012 to December 31, 2011. The remaining unvested shares of restricted stock held by Dr. Heacox expired in
accordance with their terms on December 31, 2011; and 

  

	 	•	 	 With respect to Dr. Heacox’s unused vacation time, the Committee approved the payment of 92 hours of vacation time for an aggregate payment
of $12,828.48.Summary of Compensation Arrangements with Non-Employee Directors

 Exhibit 10.44 
 SUMMARY OF COMPENSATION ARRANGEMENTS 
 WITH NON-EMPLOYEE DIRECTORS

 (Effective as of December 31, 2011) 
 The following summarizes the compensation and benefits received by the non-employee Directors of CryoLife as of December 31, 2011. It is intended to be a summary of compensation arrangements, and in
no way is intended to provide any additional rights to any non-employee Director. 
 Annual Retainer and Committee Chair Fees 

Each of the non-employee Directors of the Board of Directors of CryoLife receives an annual cash retainer of $40,000. Each committee chair
also receives a fee in addition to the annual cash retainer in the amounts shown in the following table. 
  

					
	 Annual Fees For Committee Chairs
	 
	 Audit Committee
	  	$	15,000	  
	 Compensation Committee
	  	$	10,000	  
	 Nominating and Corporate Governance Committee
	  	$	7,500	  
	 Regulatory Affairs and Quality Assurance Policy Committee
	  	$	7,500	  

 The Presiding Director also receives an additional $25,000 retainer, with $10,000 paid in cash and
$15,000 paid in restricted stock that vests 12 months after the date of issuance. CryoLife pays all cash retainers on a monthly basis. 

Restricted Stock Grants 

Non-employee Directors of CryoLife are eligible for equity grants, which are generally made in May of each year. The annual equity portion
of non-employee Director compensation for fiscal 2011 was paid in the form of a grant of 10,000 shares of restricted stock. These shares were issued following the annual meeting of stockholders and vest on the first anniversary of issuance. The
size and terms of the annual equity grant are subject to annual reevaluation by the Compensation Committee. If a Director ceases to serve as a Director for any reason, he will forfeit any unvested portion of the award.First Amendment to Loan and Security Agreement

 Exhibit 10.56(a) 

AMENDMENT TO 
 LOAN AND SECURITY AGREEMENT 
 THIS AMENDMENT TO LOAN
AND SECURITY AGREEMENT (this “Amendment”) is made effective as of the 6th day of September, 2011, by and between VALVEXCHANGE, INC., a Delaware corporation (the “Borrower”) and CRYOLIFE, INC., a Florida corporation (together with its successors and assigns, the
“Lender”). 
 R E C I T A L S: 
 The Borrower and the Lender have entered into that certain Loan and Security Agreement dated as of July 6, 2011 (the “Loan Agreement”). Capitalized terms used in this Amendment which are
not otherwise defined in this Amendment shall have the respective meanings assigned to them in the Loan Agreement. 
 The
Borrower and the Lender wish to amend the Loan Agreement in certain respects. 
 NOW, THEREFORE, in consideration of the
Recitals and the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Borrower and the Lender, intending to be legally bound hereby, agree as follows:

 SECTION 1. Recitals. The Recitals are incorporated herein by reference and shall be deemed to be a part of this
Amendment. 
 SECTION 2. Amendment. The Loan Agreement is hereby amended as set forth in this Section 2: 

(a) Subsection (b) of Section 6.13 of the Loan Agreement, is hereby deleted in its entirety. 

(b) Subsection (a)(v) of Section 4.1 of the Loan Agreement is hereby amended to read as follows: 

“(v) (A) A deposit account control agreement fully executed by and among Lender, Borrower and KeyBank National
Association or such other bank or other financial institution at which any deposit accounts, securities accounts or commodities accounts are held and (B) a legal opinion opining to such matters as Lender may request in respect of such control
agreements, including but not limited to the corporate authority for and enforceability of such control agreements and the creation and perfection of Lender’s security interest in the accounts set forth in.” 

SECTION 3. Conditions to Effectiveness. The effectiveness of this Amendment and the obligations of the Lender hereunder are
subject to the following conditions, unless the Lender waives such conditions: 
 (a) receipt by the Lender from each of the
parties hereto of a duly executed original counterpart of this Amendment signed by such party; and 

 (b) the fact that the representations and warranties of the Borrower contained in Article
V of the Loan Agreement and Section 5 of this Amendment shall be true on and as of the date hereof. 
 SECTION
4. No Other Amendment. Except for the amendments set forth above, the text of the Loan Agreement shall remain unchanged and in full force and effect. This Amendment is not intended to effect, nor shall it be construed as, a novation. The Loan
Agreement and this Amendment shall be construed together as a single agreement. Nothing herein contained shall waive, annul, vary or affect any provision, condition, covenant or agreement contained in the Loan Agreement, except as herein amended,
nor affect or impair any rights, powers or remedies under the Loan Agreement as hereby amended. The Lender does hereby reserve all of its rights and remedies against all parties who may be or may hereafter become secondarily liable for the repayment
of the Note. The Borrower promises and agrees to perform all of the requirements, conditions, agreements and obligations under the terms of the Loan Agreement, as hereby amended, the Loan Agreement being hereby ratified and affirmed. The Borrower
hereby expressly agrees that the Loan Agreement, as amended, is in full force and effect. 
 SECTION 5. Representations and
Warranties. The Borrower hereby represents and warrants to the Lender as follows: 
 (a) No Default or Event of Default, nor
any act, event, condition or circumstance which with the passage of time or the giving of notice, or both, would constitute an Event of Default, under the Loan Agreement or any other Loan Document has occurred and is continuing unwaived by the
Lender on the date hereof. 
 (b) The Borrower has the power and authority to enter into this Amendment and to do all acts and
things as are required or contemplated hereunder to be done, observed and performed by it. 
 (c) This Amendment has been duly
authorized, validly executed and delivered by one or more authorized officers of the Borrower and constitutes the legal, valid and binding obligations of the Borrower enforceable against the Borrower in accordance with its terms, provided that such
enforceability is subject to general principles of equity. 
 (d) The execution and delivery of this Amendment and the
Borrower’s performance hereunder do not and will not require the consent or approval of any regulatory authority or governmental authority or agency having jurisdiction over the Borrower, nor be in contravention of or in conflict with the
certificate of incorporation or bylaws of the Borrower, or the provision of any statute, or any judgment, order, indenture, instrument, agreement or undertaking, to which the Borrower is party or by which the Borrower’s assets or properties are
or may become bound. 
 SECTION 6. Counterparts. This Amendment may be executed in multiple counterparts, each of which
shall be deemed to be an original and all of which, taken together, shall constitute one and the same agreement. 

  
 2 

 SECTION 7. Governing Law. This Amendment shall be construed in accordance with and
governed by the laws of the State of Georgia. This Amendment is intended to be effective as an instrument executed under seal. 

SECTION 8. Essence of Time. Time is of the essence of this Amendment. 

SECTION 9. Fees and Expenses. Borrower hereby agrees that all fees and expenses (including, but not limited to, reasonable legal
fees of the Lender’s counsel) incurred in connection with the preparation and execution of this Amendment shall be borne by the Borrower. 
 [SIGNATURE PAGE FOLLOWS] 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have executed and delivered, or have caused their
respective duly authorized officers or representatives to execute and deliver, this Amendment as of the day and year first above written. 
  

			
	BORROWER:
	
	VALVEXCHANGE, INC.
		
	By:	 	 /s/ Larry O. Blankenship

	Name:	 	 Larry O. Blankenship

	Title:	 	 CEO

	
	[CORPORATE SEAL]
	
	LENDER:
	
	CRYOLIFE, INC.
		
	By:	 	 /s/ D. A. Lee

	Name:	 	 D. A. Lee

	Title:	 	 EVP, COO and CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]